Minerva Neurosciences
NERV
12 hedge funds and large institutions have $13.6M invested in Minerva Neurosciences in 2014 Q3 according to their latest regulatory filings, with 12 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
9.07% more ownership
Funds ownership: 0% → 9.07% (+9.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$10M |
| 2 |
Catalyst Capital Advisors
Huntington,
New York
|
+$1.96M |
| 3 |
Cormorant Asset Management
Boston,
Massachusetts
|
+$1.16M |
| 4 |
Highland Capital Management (Texas)
Dallas,
Texas
|
+$947K |
| 5 |
Goldman Sachs
New York
|
+$307K |
Top Sellers
NERV Hedge Fund Activity: Q3 2014 in Review
12 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q3 2014, worth a combined $13.6M.
Buyers outnumbered sellers: 12 funds opened new NERV positions and 0 closed out — a net gain of 12 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $10M.
- 12 institutional investors held Minerva Neurosciences (NERV) as of Q3 2014, up from 0 in Q2 2014.
- Funds reported $13.6M of Minerva Neurosciences stock for Q3 2014.
- 12 funds opened new Minerva Neurosciences positions in Q3 2014 and 0 closed out, a net change of +12 holders.
- The largest Minerva Neurosciences buyer in Q3 2014 was Fidelity Investments, an estimated $10M added.
Based on aggregated 13F filings for Q3 2014.